This week’s reported global health innovation funding included:

Science, an Alameda, CA-based full-stack neural engineering company focused on solving some of medicine's hardest problems and most serious unmet medical needs, raised $230M from Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT, and Quiet Capital. <source>

Cognito Therapeutics, a Cambridge, MA-based developer of a sensory stimulus medical device delivering gamma-frequency light and sound to address the neurological underpinnings of Alzheimer's disease, raised $105M led by Morningside Ventures, IAG Capital Partners, and Starbloom Capital, with participation from New Vintage, Apollo Health Ventures, and Benvolio Group. <source>

Sage, a New York, NY-based provider of an AI-powered integrated care platform for senior living and skilled nursing facilities featuring predictive fall prevention, real-time resident monitoring, and deep EHR integrations, raised $65M led by Growth Equity at Goldman Sachs Alternatives, with participation from IVP and Goldcrest. <source>

Eight Sleep, a New York, NY-based developer of AI-powered smart sleep technology including temperature-regulating mattresses and sleep apnea detection and mitigation tools seeking FDA clearance, raised $50M led by Tether Investments. <source>

Greater Good Health, an El Segundo, CA-based operator of a nurse practitioner-led primary care model for complex Medicare populations under value-based care arrangements, raised $33M consisting of a $20.5M Series B led by Allumia Ventures, with participation from DaVita Venture Group, Granite Financial Holdings, Flare Capital Partners, Optum Ventures, LRVHealth, Health Velocity, Martin Ventures, and Epsilon Ventures, alongside up to $12.5M in venture debt from HSBC Innovation Banking. <source>

Aneuvo, a Los Angeles, CA-based developer of a non-invasive neuromodulation system for functional rehabilitation in patients with spinal cord injury, raised $22M led by Catcher Technology Co, with participation from additional undisclosed investors. <source>

Minnesota Medical Technologies Corporation, a Stewartville, MN-based developer of an FDA-cleared single-use device for managing fecal incontinence, created in collaboration with Mayo Clinic gastroenterologist Dr. Adil Bharucha, raised $20.6M co-led by HM Venture Partners and Southeast Minnesota Capital Partners. <source>

NexCure, a Boston, MA-based AI-enabled oncology platform launching from stealth to expand access to CAR-T and other advanced therapies in community outpatient settings, raised $19M led by RA Capital Management, with participation from Cencora Ventures and Oncology Ventures. <source>

TruDoc, a Dubai, UAE-based virtual-first healthcare platform offering telehealth, chronic disease management, pharmacy-at-home, diagnostics, and hospital-at-home services across the GCC, raised $15M from the Al Nahyan family and the Al-Ketbi family, with participation from Pulsar Capital. <source>

ARK, a South Korea-based AI chronic disease screening startup offering AI-based screening for macular degeneration, glaucoma, diabetic retinopathy, and cardiovascular and kidney disease risk, raised $13.7M (~₩20B) led by DSC Investment, with participation from Kiwoom Investment, Aju IB Investment, SL Investment, Platinum Technology Investment, and Wooshin Ventures. <source>

Amigo AI, a New York, NY-based platform for building and training patient-facing clinical AI agents across use cases including intake and triage, care navigation, and 24/7 patient support, with native integrations into all major EHRs, raised $11M led by Madrona, with participation from Optum Ventures. <source>

Join StartUp Health

A global community for the bold decision makers, thought leaders, funders, and innovators transforming the future of health – this is where the global health ecosystem comes together to learn from experts, share insights, build relationships, explore partnerships, and shape what’s next in health.

👉 Join today, no application necessary

Antiverse, a Cardiff, Wales, UK-based AI-driven techbio company designing therapeutic antibodies for historically undruggable targets including GPCRs and ion channels, raised $9.3M led by Soulmates Ventures, with participation from Innovation Investment Capital, DOMiNO Ventures, DBW, Kadmos Capital, and i&i Biotech Fund. <source>

UnityAI, a Nashville, TN-based provider of an agentic AI workforce platform for healthcare operations covering patient scheduling, referral management, follow-ups, staffing coordination, and insurance verification, raised $8.5M led by Third Prime, with participation from Nashville Capital Network, Whistler Capital Partners, Max Ventures, and Company Ventures. <source>

Xsensio, a Lausanne, Switzerland-based developer of a wearable biosensing platform enabling continuous real-time monitoring of metabolites, ions, proteins, and hormones through interstitial fluid, raised $7M led by WI Harper, with participation from Privilège Ventures, the European Innovation Council, and private investors. <source>

Cent, a Bengaluru, India-based direct-to-consumer preventive health intelligence platform combining whole-body MRI, low-dose CT, DEXA, ECG, and 120+ biomarkers with AI synthesis to identify cancer, cardiac, neurological, and metabolic risk in asymptomatic patients, raised $5M led by OneFlow Holdings, with participation from South Park Commons. <source>

Procode AI, a Los Angeles, CA-based AI-powered revenue cycle management company for surgeons in private practice offering a coding copilot that translates operative reports to billing codes 90% faster, raised $4M led by Story Ventures, with participation from CHAP Health Ventures, Progression Fund, and Dmitry Shevelenko. <source>

Qura, a Milan, Italy-based developer of an AI-driven preventive health platform combining blood testing, AI analysis, and physician consultations to address subclinical symptoms including chronic fatigue, hormonal imbalances, and digestive issues, raised $1.74M (€1.5M) led by United Ventures, with participation from Vento, Italian Angels for Growth, and individual angel investors. <source>

Noctem Health, a Pittsburgh, PA-based University of Pittsburgh spinout providing a remote monitoring platform for evidence-based insomnia treatment that enables healthcare providers to deliver behavioral sleep medicine without referrals or waitlists, raised $1.4M from undisclosed investors. <source>

Illume, a Cincinnati, OH-based provider of a real-time intelligence platform for med spa and aesthetics practice owners delivering prescriptive insights across revenue, marketing, patient experience, and operations, raised an undisclosed amount led by Keyhorse Capital, with participation from Cintrifuse Capital. <source>

Today’s Sponsor

If You Could Be Earlier Than 85% of the Market?

Most read the move after it runs. The top 250K start before the bell.

Elite Trade Club turns noise into a five-minute plan—what’s moving, why it matters, and the stocks to watch now. Miss it and you chase.

Catch it and you decide.

By joining, you’ll receive Elite Trade Club emails and select partner insights. See Privacy Policy.

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Follow us on LinkedIn for daily updates on Health Moonshots.

Keep Reading